Literature DB >> 33618736

Traditional Chinese herbal medicine-potential therapeutic application for the treatment of COVID-19.

Jillian L Capodice1, Barbara M Chubak2.   

Abstract

Traditional Chinese Medicine (TCM) is a complete medical system that has evolved over millennia to include practices and procedures such as acupuncture, herbal medicine, manual therapies, nutrition, and mind-body therapies such as qi gong. In modern-day China and other Asian countries, TCM is a medical subspecialty utilized alongside western biomedicine. During the current Coronavirus Disease 19 (COVID-19) pandemic, TCM and TCM herbal medicine is being used and a number of single herbs and combination formulas have significant bioactivity and therapeutic potential. The purpose of this paper is to highlight the use of TCM in the treatment of COVID-19. This commentary provides the reader with a concise background on COVID-19 and summarizes TCM concepts including identification, pattern diagnosis, and treatment principles commonly used for the treatment of viral influenza-like diseases. It also highlights some of the challenges and potential for using TCM in an integrated medical setting.

Entities:  

Keywords:  COVID; COVID-19; Chinese medicine; Herbal medicine; TCM

Year:  2021        PMID: 33618736      PMCID: PMC7897885          DOI: 10.1186/s13020-020-00419-6

Source DB:  PubMed          Journal:  Chin Med        ISSN: 1749-8546            Impact factor:   5.455


  24 in total

1.  Clinical Characteristics of Covid-19 in China. Reply.

Authors:  Wei-Jie Guan; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-03-27       Impact factor: 91.245

2.  The embryonic origin of endocrine cells of the gastrointestinal tract.

Authors:  A Andrew; B Kramer; B B Rawdon
Journal:  Gen Comp Endocrinol       Date:  1982-06       Impact factor: 2.822

3.  Endolymphatic-mastoid shunt operation: results of the 24 cases and revision surgery with the silastic sheet.

Authors:  K Gyo; N Yanagihara
Journal:  Auris Nasus Larynx       Date:  1982       Impact factor: 1.863

4.  Characterization of two new electrophoretic variants of human triosephosphate isomerase: stability, kinetic, and immunological properties.

Authors:  J Asakawa; H W Mohrenweiser
Journal:  Biochem Genet       Date:  1982-02       Impact factor: 1.890

Review 5.  The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.

Authors:  Yan-Rong Guo; Qing-Dong Cao; Zhong-Si Hong; Yuan-Yang Tan; Shou-Deng Chen; Hong-Jun Jin; Kai-Sen Tan; De-Yun Wang; Yan Yan
Journal:  Mil Med Res       Date:  2020-03-13

6.  Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.

Authors:  Lisa H Tostanoski; Frank Wegmann; Amanda J Martinot; Carolin Loos; Katherine McMahan; Noe B Mercado; Jingyou Yu; Chi N Chan; Stephen Bondoc; Carly E Starke; Michael Nekorchuk; Kathleen Busman-Sahay; Cesar Piedra-Mora; Linda M Wrijil; Sarah Ducat; Jerome Custers; Caroline Atyeo; Stephanie Fischinger; John S Burke; Jared Feldman; Blake M Hauser; Timothy M Caradonna; Esther A Bondzie; Gabriel Dagotto; Makda S Gebre; Catherine Jacob-Dolan; Zijin Lin; Shant H Mahrokhian; Felix Nampanya; Ramya Nityanandam; Laurent Pessaint; Maciel Porto; Vaneesha Ali; Dalia Benetiene; Komlan Tevi; Hanne Andersen; Mark G Lewis; Aaron G Schmidt; Douglas A Lauffenburger; Galit Alter; Jacob D Estes; Hanneke Schuitemaker; Roland Zahn; Dan H Barouch
Journal:  Nat Med       Date:  2020-09-03       Impact factor: 53.440

Review 7.  Mixed adenoneuroendocrine carcinoma of the hepatic bile duct: a case report and review of the literature.

Authors:  Sulai Liu; Zhendong Zhong; Meng Xiao; Yinghui Song; Youye Zhu; Bo Hu; Zengpeng Sun; Weimin Yi; Chuang Peng
Journal:  BMC Gastroenterol       Date:  2020-11-25       Impact factor: 3.067

8.  Deaths Associated with Pneumonic Plague, 1946-2017.

Authors:  Alex P Salam; Amanda Rojek; Erhui Cai; Mihaja Raberahona; Peter Horby
Journal:  Emerg Infect Dis       Date:  2020-10       Impact factor: 6.883

9.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.

Authors:  Alexandra C Walls; Young-Jun Park; M Alejandra Tortorici; Abigail Wall; Andrew T McGuire; David Veesler
Journal:  Cell       Date:  2020-12-10       Impact factor: 41.582

10.  Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties.

Authors:  Michael A Matthay; B Taylor Thompson
Journal:  Lancet Respir Med       Date:  2020-10-29       Impact factor: 30.700

View more
  4 in total

Review 1.  Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Javed Muhammad; Amjad Khan; Anupam A Sule; Raghavendra Tirupathi; Abbas Al Mutair; Saad Alhumaid; Awad Al-Omari; Manish Dhawan; Ruchi Tiwari; Khan Sharun; Ranjan K Mohapatra; Saikat Mitra; Muhammad Bilal; Salem A Alyami; Talha Bin Emran; Mohammad Ali Moni; Kuldeep Dhama
Journal:  Vaccines (Basel)       Date:  2021-04-29

2.  Chemometric approach to find relationships between physiological elements and elements causing toxic effects in herb roots by ICP-MS.

Authors:  Adam Sajnóg; Elwira Koko; Dariusz Kayzer; Danuta Barałkiewicz
Journal:  Sci Rep       Date:  2021-10-19       Impact factor: 4.379

Review 3.  Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Mohammed A Garout; Ayman M Al-Qaaneh; Anupam A Sule; Raghavendra Tirupathi; Abbas Al Mutair; Saad Alhumaid; Abdulkarim Hasan; Manish Dhawan; Ruchi Tiwari; Khan Sharun; Ranjan K Mohapatra; Saikat Mitra; Talha Bin Emran; Muhammad Bilal; Rajendra Singh; Salem A Alyami; Mohammad Ali Moni; Kuldeep Dhama
Journal:  Pathogens       Date:  2021-05-07

Review 4.  Machine Learning Applications in Drug Repurposing.

Authors:  Fan Yang; Qi Zhang; Xiaokang Ji; Yanchun Zhang; Wentao Li; Shaoliang Peng; Fuzhong Xue
Journal:  Interdiscip Sci       Date:  2022-01-23       Impact factor: 3.492

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.